Male breast cancer (MBC) is a rare entity, underrepresented in population studies and
clinical trials, resulting in management of MBC to be informed by current research on female …

It has become customary to extrapolate from the results of treatment trials for female
breastcancer and apply them to males with the disease. In the absence of results from …

Background. Male breast cancer (MBC) is an uncommon disease and there is limited
information on the prognostic impact of routinely used clinicopathological parameters …

Male breast cancer (MBC) is rare. Due to limited information, MBC has always been
understudied. We conducted a retrospective population-based cohort study using data from …

Abstract Learning Objectives After completing this course, the reader will be able to: List the
risk factors for male breast cancer. Explain the differences between breast cancer in men …

Male breast cancer (MBC) patients seem to have inferior survival compared to female (FBC)
ones, which is not fully explained by usual prognostic factors. Recurrence analysis could …

Background Fewer than 1% of all breast cancers occur in men. As a result, a distinct lack of
data exists regarding the management and outcomes in this cohort. Methods Any male …

Aims Male breast cancer is a rare disease with limited evidence-based guidelines for
treatment. This study aimed to identify demographic, pathological and clinical factors …

Male breast cancer (MBC) is a rare disease. However, as global populace ages, there is a
trend to MBC increasing. Although aetiology is still unclear, constitutional, environmental …

Substantial controversy exists about the prognostic role of tumor subtypes in male breast
cancer (MaBC). The aim of this study was to analyze the characteristics of each tumor …